Keytruda is a medicine that's used to treat certain cancers by working with your body's immune system to detect and destroy cancer cells (called immunotherapy). Keytruda belongs to a group of medicines called immune checkpoint inhibitors. Read more about immune checkpoint inhibitors and how they work.
In Aotearoa New Zealand, Keytruda is funded for treating metastatic melanoma in people who meet the eligibility criteria.
From 1 April 2023, Keytruda is also funded for the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) for people who meet the eligibility criteria.